Author

Jeroen Michiel Jansen

REAL-WORLD IMPACT OF BIOLOGICAL THERAPIES ON WORK IMPAIRMENT AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS
REAL-WORLD IMPACT OF BIOLOGICAL THERAPIES ON WORK IMPAIRMENT AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS

Jeroen Michiel Jansen  et al.

DE-ESCALATION OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWING PRIOR ESCALATION
DE-ESCALATION OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWING PRIOR ESCALATION

Jeroen Michiel Jansen  et al.

MERCAPTOPURINE TREATMENT USING THERAPEUTIC DRUG MONITORING IS EFFECTIVE IN ULCERATIVE COLITIS: A PLACEBO-CONTROLLED RANDOMIZED TRIAL
MERCAPTOPURINE TREATMENT USING THERAPEUTIC DRUG MONITORING IS EFFECTIVE IN ULCERATIVE COLITIS: A PLACEBO-CONTROLLED RANDOMIZED TRIAL

Jeroen Michiel Jansen  et al.

SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY
SUPERIOR EFFECTIVENESS OF TOFACITINIB COMPARED TO VEDOLIZUMAB IN ANTI-TNF EXPERIENCED ULCERATIVE COLITIS PATIENTS: A NATIONWIDE DUTCH REGISTRY STUDY

Jeroen Michiel Jansen  et al.

WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY
WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY

Jeroen Michiel Jansen  et al.

COLONIZATION OF THE GASTROINTESTINAL MICROBIOTA WITH ENTEROCOCCUS AND STAPHYLOCOCCUS PREDICTS INFECTION IN PATIENTS WITH NECROTIZING PANCREATITIS (POEMA): PROSPECTIVE MULTICENTER STUDY
COLONIZATION OF THE GASTROINTESTINAL MICROBIOTA WITH ENTEROCOCCUS AND STAPHYLOCOCCUS PREDICTS INFECTION IN PATIENTS WITH NECROTIZING PANCREATITIS (POEMA): PROSPECTIVE MULTICENTER STUDY

Jeroen Michiel Jansen  et al.

LONG-TERM OUTCOME OF THE POINTER RANDOMIZED TRIAL ON IMMEDIATE VERSUS POSTPONED INTERVENTION FOR INFECTED NECROTIZING PANCREATITIS
LONG-TERM OUTCOME OF THE POINTER RANDOMIZED TRIAL ON IMMEDIATE VERSUS POSTPONED INTERVENTION FOR INFECTED NECROTIZING PANCREATITIS

Jeroen Michiel Jansen  et al.

COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL
COST-EFFECTIVENESS ANALYSIS OF INCREASED ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: ECONOMIC EVALUATION OF THE RANDOMISED CONTROLLED LADI TRIAL

Jeroen Michiel Jansen  et al.

CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL
CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL

Jeroen Michiel Jansen  et al.

LONG-TERM FOLLOW-UP OUTCOMES OF AN ENDOSCOPIC VERSUS SURGICAL STEP-UP APPROACH FOR INFECTED NECROTIZING PANCREATITIS (EXTENSION)
LONG-TERM FOLLOW-UP OUTCOMES OF AN ENDOSCOPIC VERSUS SURGICAL STEP-UP APPROACH FOR INFECTED NECROTIZING PANCREATITIS (EXTENSION)

Jeroen Michiel Jansen  et al.

Item 1 - 10 / 10
1